858 Therapeutics, Inc. has raised $25.2M in total funding. The most recent round was Series B.
858 Therapeutics, Inc. is headquartered in San Diego, CA.
858 Therapeutics (its name references San Diego's 858 area code) has raised $110M across Series A and B rounds led by Versant Ventures and Avidity Partners, with participation from NEA and Insight Partners.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.